Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06779409 · ClinicalTrials.gov registry record · NA
Impact of the Wingate Test on Post-activation Potentiation
A NA study of Performance Enhancement and Muscle Activation, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06779409: Completed NA study of Performance Enhancement and Muscle Activation, sponsored by Louisiana State University Health Sciences Center Shreveport.
NCT06779409 is a NA study of Performance Enhancement and Muscle Activation that has completed, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06779409, a NA study of Performance Enhancement and Muscle Activation, has completed, sponsored by Louisiana State University Health Sciences Center Shreveport.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this trial is to see if using a maximal effort, short cycling test is better at activating muscles to improve vertical jump height compared to a maximal effort back squat. The study looks to answer three questions: 1. will the Wingate bike test create a different change in counter movement jump height compared to a back squat? 2. What is the best recovery period after each test where the counter movement jump is the highest? 3. What person-specific factors predict success of the Wingate bike test as a activation activity for the counter movement jump? Participants will visit the lab 3 times, once to give informed consent and measure their 1 repetition max (RM) back squat, and twice to perform each intervention and measure vertical jump height.
Primary Outcome
Measured with the Counter Movement Jump (CMJ). This measures the vertical distance a participant is able to jump from a standing, stationary position. Video capture and motion analysis software will be used to analyze the jump and determine vertical displacement of a marker placed at the participants sacrum. Vertical jump height will be measured in meters.
Conditions Studied
Interventions
- OTHER Back squat
- OTHER Wingate test
Study Locations (1)
Louisiana
- LSU Health Shreveport School of Allied Health Professions - Shreveport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-01-14 |
| Est. Completion | 2025-04-25 |
| Phase | NA |
What the finished NCT06779409 record still lists
NCT06779409 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Performance Enhancement appearing as the primary indexed condition, and to 2 interventions - of which Back squat is the first listed.
NCT06779409 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT06779409 about?
NCT06779409 is a clinical study titled "Impact of the Wingate Test on Post-activation Potentiation". The goal of this trial is to see if using a maximal effort, short cycling test is better at activating muscles to improve vertical jump height compared to a maximal effort back squat. The study looks to answer three questions: 1. will the Wingate bike test create a different change in counter movem...
What is the current status of trial NCT06779409?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2025-01-14. Estimated completion is 2025-04-25.
What conditions does trial NCT06779409 study?
This clinical trial studies the following conditions: Performance Enhancement, Muscle Activation.
What interventions are being tested in trial NCT06779409?
The interventions under investigation include: Back squat (OTHER), Wingate test (OTHER).
Who is sponsoring clinical trial NCT06779409?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06779409 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Performance Enhancement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06779409's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI